Bacillus Coagulans Market Opportunity Analysis and Industry Forecast
Bacillus Coagulans Market by Type (Type 1, Type 2, and Type 3) and Application (Food, Drugs, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023
- Report Number: 5012
- Publish Date: 24-May-2018
Bacillus coagulans is beneficial bacteria used correspondingly to lactobacillus and other probiotics. It is used for treatment of diarrhea, including infectious types such as traveler’s diarrhea, rotaviral diarrhea in children, and diarrhea caused by antibiotics. In addition, it used for the treatment of irritable bowel syndrome (IBS), general digestion problems, inflammatory bowel disease (IBD, Crohn’s disease, and ulcerative colitis), and infection due to ulcer-causing bacterium Helicobacter pylori. It is used to improve the immune system to prevent respiratory infections and cancer or the formation of cancer-causing agents.
The global Bacillus coagulans market has witnessed significant growth opportunities, owing to increase in health concerns around the world and rise in demand for functional foods. In addition, rise in investments on R&D activities propel the market growth. However, lack of awareness among consumers about the effectiveness of Bacillus coagulans restrains the market growth. Rise in demand for Bacillus coagulans products in emerging economies is expected to provide growth opportunities for the market.
The global Bacillus coagulans market is segmented based on type, application, and geography. On the basis of type, the market is categorized into type 1, type 2, and type 3. Applications covered in the study include food, drugs, and others. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major players operating in the global market are focusing on key market strategies such as mergers, acquisitions, collaborations, and partnerships.
Some of the key players in the global market include:
- Sabinsa Corporation
- Nebraska Cultures Inc.
- Syngen Biotech Co.
- Unique Biotech
- Aumgene Biosciences
- Mystical Biotec
- This report provides a quantitative analysis of the current trends, estimations, and dynamics from 2016 to 2023 to assist to identify the prevailing market opportunities.
- Major countries in each region are mapped according to the individual market revenue.
- The region-wise and country-wise market conditions are comprehensively analyzed.
- This study evaluates the competitive landscape and the value chain analysis to understand the competitive environment across geographies.
- An in-depth analysis of each segment is provided to assist the prevailing market opportunities.
Bacillus Coagulans Market Key Segments:
- Type 1
- Type 2
- Type 3
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- South Africa
- Rest of LAMEA
Table of Content
Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.4.1. Secondary research
Chapter: 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2.1. Top investment pockets
3.3. MARKET SHARE ANALYSIS, 2016
3.4.1. MARKET DYNAMICS
Chapter: 4 GLOBAL BACILLUS COAGULANS MARKET, BY TYPE
4.1.1. Market size and forecast
4.2. TYPE 1
4.2.1. Key market trends
4.3. TYPE 2
4.3.1. Key market trends
4.4. TYPE 3
4.4.1. Key market trends
Chapter: 5 GLOBAL BACILLUS COAGULANS MARKET, BY APPLICATION
5.1.1. Market size and forecast
5.2.1. Key market trends
5.3.1. Key market trends
5.4.1. Key market trends
Chapter: 6 GLOBAL BACILLUS COAGULANS MARKET, BY GEOGRAPHY
6.2.1. Key market trends
22.214.171.124. By Type
126.96.36.199. Market size and forecast, by Type
188.8.131.52. Market size and forecast, by Type
184.108.40.206. Market size and forecast, by Type
6.3.1. Key market trends
220.127.116.11. By Type
18.104.22.168. Market size and forecast, by Type
22.214.171.124. Market size and forecast, by Type
126.96.36.199. Market size and forecast, by Type
188.8.131.52. Market size and forecast, by Type
184.108.40.206. Market size and forecast, by Type
6.3.9. Rest of Europe
220.127.116.11. Market size and forecast, by Type
6.4.1. Key market trends
18.104.22.168. By Type
22.214.171.124. Market size and forecast, by Type
126.96.36.199. Market size and forecast, by Type
188.8.131.52. Market size and forecast, by Type
6.4.7. South Korea
184.108.40.206. Market size and forecast, by Type
6.4.8. Rest of Asia-Pacific
220.127.116.11. Market size and forecast, by Type
6.5.1. Key market trends
18.104.22.168. By Type
22.214.171.124. Market size and forecast, by Type
126.96.36.199. Market size and forecast, by Type
6.5.6. South Africa
188.8.131.52. Market size and forecast, by Type
6.5.7. Rest of LAMEA
184.108.40.206. Market size and forecast, by Type
Chapter: 7 COMPANY PROFILES
7.1.1. Operating business segments
7.2. SABINSA CORPORATION
7.2.1. Operating business segments
7.3.1. Operating business segments
7.4. NEBRASKA CULTURES INC.
7.4.1. Operating business segments
7.5. SYNGEN BIOTECH CO.
7.5.1. Operating business segments
7.6.1. Operating business segments
7.7. UNIQUE BIOTECH
7.7.1. Operating business segments
7.8. AUMGENE BIOSCIENCES
7.8.1. Operating business segments
7.9. MYSTICAL BIOTECH
7.9.1. Operating business segments
7.10.1. Operating business segments